Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Safety and effectiveness of vortioxetine in patients with major depressive disorder in a real-life clinical setting in India: results from an interventional, flexible-dose study.
Journal: Current medical research and opinion
Published: August 07, 2024
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study.
Journal: Journal of psychopharmacology (Oxford, England)
Published: July 30, 2024
Vortioxetine in the Treatment of Major Depressive Disorder Among Working Patients in Routine Clinical Practice: An Analysis of a Post-Marketing Surveillance Study in South Korea.
Journal: Neuropsychiatric disease and treatment
Published: May 24, 2024
Goal setting and goal attainment in patients with major depressive disorder: a narrative review on shared decision making in clinical practice.
Journal: Current medical research and opinion
Published: January 31, 2024
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets.
Journal: Journal of psychopharmacology (Oxford, England)
Published: December 21, 2023
Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder.
Journal: CNS spectrums
Published: April 18, 2023
Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study.
Journal: Journal of psychopharmacology (Oxford, England)
Published: November 15, 2022
Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer's disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea.
Journal: Frontiers in aging neuroscience
Published: September 06, 2022
The Motivation and Energy Inventory (MEI): Analysis of the clinically relevant response threshold in patients with major depressive disorder and emotional blunting using data from the COMPLETE study.
Journal: Journal of affective disorders
Published: June 15, 2022
Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: An updated analysis of efficacy and tolerability.
Journal: Journal of affective disorders
Published: June 01, 2022
Predicting time to relapse in patients with schizophrenia according to patients' relapse history: a historical cohort study using real-world data in Sweden.
Journal: BMC psychiatry
Published: August 27, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026